To date, prostate cancer remains the most common tumor diagnosed in males and the second most common cause of cancer-related mortality. While current screening protocols can detect early disease, t... Tweetable abstract In prostate cancer, there remains a need for more accurate diagnostic, prognostic and treatment-response strategies utilizing less invasive sources. As such, miRNAs are promising...